ScanSource (SCSC) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Fiscal 2024 saw declines in net sales, gross profit, and net income, but gross profit margin expanded and working capital efficiency improved, resulting in $372 million in operating cash flow and a strong balance sheet with $185 million in cash and low leverage ratios.
Two strategic acquisitions were completed in high-margin, recurring-revenue segments, and the share repurchase program was increased by $100 million, with $43.3 million in shares repurchased during the year.
The company expects continued soft demand in fiscal 2025 and will manage SG&A accordingly, while maintaining an active pipeline for acquisitions and share repurchases.
Employee engagement initiatives, such as the Voices survey and a new Employee Engagement Task Force, were launched to enhance organizational culture and responsiveness.
Community engagement and charitable activities were emphasized, especially in response to Hurricane Helene, with significant employee involvement in relief efforts.
Voting matters and shareholder proposals
Shareholders will vote on the election of eight director nominees, an advisory say-on-pay vote for executive compensation, ratification of Grant Thornton LLP as independent auditor for FY2025, and approval of the 2024 Omnibus Incentive Compensation Plan.
Shareholders of record as of October 4, 2024, are entitled to vote, with one vote per share and no cumulative voting.
Proposals require a majority of votes cast to pass; broker non-votes and abstentions do not affect outcomes for non-discretionary items.
Shareholder proposals for the 2025 meeting must be received by June 27, 2025, and comply with SEC rules and company bylaws.
Board of directors and corporate governance
The board consists of a majority of independent directors, with the CEO also serving as Chair and a Lead Independent Director providing additional oversight.
Board committees (Audit, Compensation, Nominating and Corporate Governance) are fully independent and met regularly in fiscal 2024.
Board succession planning, diversity, and annual performance evaluations are emphasized, with 37.5% of director nominees being gender, racially, or ethnically diverse.
Directors are subject to anti-pledging and anti-hedging policies, and must meet stock ownership requirements.
Shareholder engagement included outreach to holders of over 60% of shares outstanding, with feedback incorporated into governance and compensation practices.
Latest events from ScanSource
- Recurring revenues and disciplined capital allocation drive margin growth and efficiency.SCSC
47th Annual Raymond James Institutional Investor Conference5 Mar 2026 - Q2 FY26 sales grew 2.5%, but margin pressure led to reduced full-year guidance.SCSC
Q2 20265 Feb 2026 - Sales fell but margins, cash flow, and acquisitions support growth amid market uncertainty.SCSC
Q4 202423 Jan 2026 - Recurring revenue and margin gains offset sales decline; FY25 outlook reaffirmed.SCSC
Q1 202515 Jan 2026 - Hybrid distribution and recurring revenue drive growth, with a focus on cash flow and strategic M&A.SCSC
Raymond James 2024 TMT & Consumer Conference11 Jan 2026 - Sales fell 15.5% but margin and recurring revenue rose; FY25 guidance reaffirmed.SCSC
Q2 20259 Jan 2026 - Recurring revenue now exceeds 30% of gross profit, fueling margin expansion and strategic growth.SCSC
Raymond James & Associates’ 46th Annual Institutional Investors Conference 202514 Dec 2025 - Transformation to a converged hardware and recurring revenue model drives growth and margin expansion.SCSC
Raymond James TMT and Consumer Conference10 Dec 2025 - Strong cash flow, margin growth, and governance focus highlight FY2025, with key votes ahead.SCSC
Proxy Filing1 Dec 2025